The Scripps Research Institute

Date of Award

10.07.2026

Program

Therapeutics

Amount

$5,891,497.00

Term of Grant

36 months

Project Title

RESET-CD: A Phase 2a Study of CLF065, a Long-Acting GLP-2 Regenerative Therapy

Project Description

The aim of this project is to determine whether CLF065, a long acting GLP-2 agonist, can safely induce mucosal repair and improve endoscopic outcomes when added to ongoing anti-IL-23 therapy in CD patients.